BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.24 -1.9%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

BioCryst Pharmaceuticals Financial Statements 2011-2024 | BCRX

Annual Financial Statements BioCryst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.12 B 1.68 B 2.98 B 1.8 B 324 M 899 M 385 M 445 M 508 M 680 M 573 M 78.2 M 158 M

Shares

192 M 186 M 179 M 167 M 116 M 103 M 84.5 M 73.7 M 72.9 M 66.8 M 55.2 M 49.5 M 45.1 M

Historical Prices

5.85 9.04 16.6 10.8 3 8.26 4.97 6.24 1.99 10.2 11.7 1.2 4.66

Net Income

-227 M -247 M -184 M -183 M -109 M -101 M -65.8 M -55.1 M -43 M -45.2 M -30.1 M -39.1 M -56.9 M

Revenue

331 M 271 M 157 M 17.8 M 48.8 M 20.7 M 25.2 M 26.4 M 48.3 M 13.6 M 17.3 M 26.3 M 19.6 M

Cost of Revenue

4.48 M 6.41 M 7.23 M 1.55 M 3.73 M - 1.14 M 2.3 M - - - - -

Gross Profit

- - - - 44.7 M 20.2 M 23.5 M 23.7 M 46.4 M 13.5 M 17.2 M 26.2 M 19.6 M

Operating Income

-104 M -148 M -178 M -175 M -99.5 M -94.2 M -57.4 M -48.6 M -39.4 M -45.8 M -30.7 M -33.9 M -49.6 M

Interest Expense

108 M 99.1 M 59.3 M 14.5 M 11.9 M 9.18 M 8.56 M 6.49 M 5.2 M 5 M 4.78 M 4.67 M 3.77 M

EBITDA

-102 M -147 M -177 M -174 M -98.7 M -93.4 M -56.7 M -48.1 M -39.3 M -45.6 M -30.4 M -31.5 M -48.7 M

Operating Expenses

- - - - 144 M 114 M 80.9 M 72.3 M 85.8 M 59.3 M 48 M 58.3 M 69.2 M

General and Administrative Expenses

214 M 159 M 119 M 67.9 M 37.1 M 29.5 M 13.9 M 11.3 M 13 M 7.46 M 5.22 M 6.83 M 12.3 M

All numbers in USD currency

Quarterly Income Statement BioCryst Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

207 M 206 M 206 M 206 M 190 M 189 M 189 M 188 M 186 M 186 M 185 M 184 M 179 M 179 M 178 M 177 M 177 M 177 M 177 M 154 M 154 M 154 M 154 M 110 M 110 M 110 M 110 M 98.4 M 98.4 M 98.4 M 98.4 M 73.8 M 73.8 M 73.7 M 73.8 M 73.4 M 73.4 M 72.6 M 72.3 M 72 M 72 M 63.6 M 59.6 M 59.1 M 59.1 M 59.1 M 59.1 M 50.9 M 50.9 M 50.9 M 50.9 M 45.7 M 45.7 M 45.7 M 45.7 M

Net Income

-14 M -12.7 M -35.4 M - -36.1 M -75.3 M -53.3 M - -42.5 M -58.9 M -74.2 M - -58.8 M -43.2 M -64.3 M -60.5 M -46.1 M -38.6 M -37.6 M -2.62 M -37.6 M -37.6 M -31.1 M -27.4 M -29.6 M -18.4 M -25.8 M -19.5 M -15.1 M -16.9 M -14.2 M -4.5 M -11.5 M -16.3 M -22.8 M -18.1 M -14.6 M 4.9 M -15.2 M -11.7 M -8.73 M -14.6 M -10.1 M -5.43 M -8 M -12.2 M -4.51 M -11.1 M -9.7 M -12.3 M -6.05 M -13.2 M -14.5 M -16.3 M -13 M

Revenue

117 M 109 M 92.8 M - 86.7 M 82.5 M 68.8 M - 75.8 M 65.5 M 49.9 M - 41 M 50 M 19.1 M 4.02 M 6.1 M 2.87 M 4.82 M 39.7 M 1.78 M 1.45 M 5.89 M 2.73 M 1.45 M 12.5 M 3.98 M 3.89 M 8.76 M 3.1 M 9.44 M 8.98 M 7.76 M 4.79 M 4.82 M 4.6 M 11 M 25.8 M 6.83 M 5.45 M 3.24 M 1.47 M 3.46 M 10.6 M 2.39 M 821 K 3.55 M 4.1 M 5.76 M 4.21 M 12.2 M 5.22 M 5.25 M 3.74 M 5.44 M

Cost of Revenue

3.21 M 1.7 M 1.26 M - 1.1 M 894 K 931 K - 3.54 M 246 K 236 K - 591 K 297 K 5.92 M - 1.52 M - - - - - 1.4 M - - - - - 1.14 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

7.69 M 8.76 M -14.5 M - -11.9 M -20.7 M -28.4 M - -17.4 M -34.7 M -50 M - -44.6 M -29.6 M -51.4 M - -42.9 M -38.5 M -41 M - -35.1 M -34.9 M -29.3 M - -28.5 M -18.3 M -22.2 M - -13.3 M -15.5 M -10.7 M - -9.24 M -12.1 M -19 M - -13.2 M 5.34 M -14.4 M - -11.6 M -11.6 M -7.39 M - -6.92 M -12.1 M -5.32 M - -8.02 M -10.2 M -5 M - -12.8 M -14.2 M -11.5 M

Interest Expense

- 24.7 M 24.5 M - 27.3 M 28.9 M 27.4 M - 24.8 M 24 M 23.8 M - 14.1 M 13.5 M 12.9 M - 2.93 M 2.92 M 3.05 M - 3.04 M 3.04 M 2.73 M - 2.35 M 2.2 M 2.22 M - 2.14 M 2.09 M 2.1 M - 1.46 M 1.42 M 1.47 M - 1.24 M 1.31 M 1.32 M - 1.22 M 1.22 M 1.24 M - 1.19 M 1.16 M 1.18 M - 1.17 M 1.16 M 1.16 M - 1.16 M 1.17 M 288 K

EBITDA

- - -14.2 M - - - -28 M - -16.4 M -34.7 M -49.6 M - -44 M -29.6 M -51.2 M - -42.3 M -38.1 M -40.8 M - -34.6 M -34.6 M -29.2 M - -27.9 M -17.9 M -22 M - -12.8 M -15.2 M -10.5 M - -8.93 M -12 M -19 M - -13 M 5.44 M -14.4 M - -11.5 M -11.5 M -7.33 M - -6.68 M -12 M -5.22 M - -7.56 M -9.85 M -4.83 M - -12.2 M -13.8 M -11.5 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

65.1 M 61.2 M 59.4 M - 50.6 M 51 M 47.9 M - 36.9 M 38 M 34.3 M - 35 M 26.3 M 22.1 M - 17.2 M 13.9 M 15.9 M - 11.7 M 8.66 M 6.24 M - 7.92 M 9.49 M 7.61 M - 3.34 M 2.83 M 3.06 M - 2.76 M 2.72 M 3.21 M - 2.73 M 3.53 M 4.06 M - 1.81 M 2.01 M 1.59 M - 1.58 M 1.43 M 1.58 M - 1.59 M 1.61 M 1.7 M - 2.95 M 3.54 M 3.53 M

All numbers in USD currency